📰 One Partnering News
Page 2 - One Partnering News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from One Partnering. Real-time updates on events, politics, business and more.
February 2, 2023
Investegate announcements from Laxxon Medical, Laxxon Medical to Participate in the BIO CEO & Investor Conference
February 2, 2023
NEW YORK, NY / ACCESSWIRE / February 2, 2023 / Laxxon Medical, a pharma-technology company pioneering innovative 3D screen printed pharmaceutical solutions, announced today their participation in the BIO
February 2, 2023
02.02.2023 - NEW YORK, NY / ACCESSWIRE / February 2, 2023 / Laxxon Medical, a pharma-technology company pioneering innovative 3D screen printed pharmaceutical solutions, announced today their participation in the BIO CEO & Investor Conference taking place at the ...
January 25, 2023
CEO Stephen C. Glover to provide key updates on the development status of ZyVersa’s Phase 2a-ready cholesterol efflux mediator VAR 200 for renal disease...
January 19, 2023
/PRNewswire/ - Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), announced that Bruce Pritchard, Chief Executive Officer at...
January 19, 2023
/PRNewswire/ -- Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), announced that Bruce Pritchard, Chief Executive Officer at...
January 19, 2023
LAVAL, QC and CAMBRIDGE, England, Jan. 19, 2023 /PRNewswire/ -- Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), announced that Bruce Pritchard, Chief Executive
January 19, 2023
/PRNewswire/ -- Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), announced that Bruce Pritchard, Chief Executive Officer at...
January 19, 2023
/PRNewswire/ - Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), announced that Bruce Pritchard, Chief Executive Officer at...
January 11, 2023
ZURICH, SWITZERLAND / ACCESSWIRE / January 11, 2023 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and